The ability to identify and evaluate the severity of tau pathology in the brain may further assist affirmative diagnosis of AD and disease progression staging, possibly even after beta-amyloid deposition plateaus, and offer evaluation of potential anti-tau treatment efficacy.
Type: disease_model
Confidence Level: supported
Diseases Associated: Alzheimer's disease
Number of Supporting Papers: 1
Source Papers:
Pathophysiology of Tau in AD